Now Playing
Opinion|Videos|September 9, 2024
The Impact of CRM Diseases in the US: Burden, Prevalence, and Obesity
Key Takeaways
- CRM conditions significantly impact clinical outcomes and quality of life, increasing healthcare resource utilization.
- Obesity, prevalent in over 42% of adults, exacerbates the prevalence and impact of CRM conditions.
A panel of experts examines the impact of cardiometabolic diseases in the United States, focusing on their burden, prevalence, and relationship to obesity.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the clinical and economic burden of Cardiorenal Metabolic Disease (CRM) conditions such as type 2 diabetes, chronic kidney disease, cardiovascular disease and heart failure in the United States?
- How do CRM conditions affect patient quality of life and clinical outcomes?
- How do these conditions impact healthcare resource utilization?
- The CDC has announced that over 42% of adults have obesity; what role does obesity play in the prevalence of CRM conditions in the United States?
- Is this your experience in your practice?
This activity is supported by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company who provided financial support for this program.
Advertisement
Related to this article
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.
CDC's David A. Siegel, MD, MPH, on rising cancer diagnoses, falling deaths, and where CDC's cancer control resources go next.
CDC's Jane Henley, MSPH, explains what's behind falling lung cancer deaths and why 4 in 5 eligible adults still aren't getting screened.
Machine learning identified age, BMI, income, and reproductive factors as key predictors of overactive bladder risk among US women.
Tammy Lundstrom, MD, JD, discusses the new childhood vaccine order, single-dose MMR access concerns, and the measles resurgence.
Advertisement
Advertisement